We are live on
!
Find out more
GS
Gagnon Securities Portfolio holdings
AUM
$519M
1-Year Est. Return
44.91%
This Fund
S&P 500
This Quarter
Est. Return
+1.54%
1 Year Est. Return
+44.91%
3 Year Est. Return
+129.38%
5 Year Est. Return
+108.07%
10 Year Est. Return
+1,389.15%
AUM
$464M
AUM Growth
+$5.1M
(+1.1%)
Cap. Flow
+$5.72M
Cap. Flow
% of AUM
1.23%
Top 10 Holdings %
Top 10 Hldgs %
43.18%
Holding
100
New
3
Increased
45
Reduced
38
Closed
3
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pacira BioSciences
PCRX
|
+$11.8M |
| 2 |
ZUO
Zuora, Inc.
ZUO
|
+$6.35M |
| 3 |
Navigator Holdings
NVGS
|
+$3.95M |
| 4 |
Yext
YEXT
|
+$2.66M |
| 5 |
NEX
NexTier Oilfield Solutions Inc.
NEX
|
+$2.31M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AMBR
Amber Road Inc
AMBR
|
+$12M |
| 2 |
ELLI
Ellie Mae Inc
ELLI
|
+$11.1M |
| 3 |
INST
Instructure, Inc.
INST
|
+$2.59M |
| 4 |
CareDx
CDNA
|
+$2.55M |
| 5 |
EVBG
Everbridge, Inc. Common Stock
EVBG
|
+$2.06M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 24.85% |
| 2 | Technology | 24.09% |
| 3 | Industrials | 16.48% |
| 4 | Consumer Discretionary | 8.81% |
| 5 | Energy | 8.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
Chegg
CHGG
$104M
| $266K | 0.06% |
6,889
-676
| -9% | -$25.5K |
|
|
TTOO
77
DELISTED
T2 Biosystems, Inc
TTOO
| $250K | 0.05% |
30
| – | – |
|
|
TTSH
78
DELISTED
Tile Shop Holdings
TTSH
| $247K | 0.05% |
61,803
+204
| +0.3% | +$970 |
|
79
Wells Fargo
WFC
$267B
| $244K | 0.05% |
5,163
| – | – |
|
80
Synchrony
SYF
$25.9B
| $243K | 0.05% |
7,014
-100
| -1% | -$3.39K |
|
81
Bristow Group
VTOL
$1.36B
| $219K | 0.05% |
13,110
-49
| -0.4% | -$876 |
|
82
Denison Mines
DNN
$2.89B
| $192K | 0.04% |
362,791
-712
| -0.2% | -$373 |
|
|
APTO
83
DELISTED
Aptose Biosciences, Inc.
APTO
| $146K | 0.03% |
+124
| New | +$114K |
|
84
GE Aerospace
GE
$398B
| $144K | 0.03% |
2,758
| – | – |
|
85
Range Resources
RRC
$8.98B
| $135K | 0.03% |
19,357
-71
| -0.4% | -$617 |
|
86
TherapeuticsMD
TXMD
$23.5M
| $49K | 0.01% |
373
| – | – |
|
|
AMBR
87
DELISTED
Amber Road Inc
AMBR
| – | – |
-1,380,369
| Closed | -$12M |
|
|
ELLI
88
DELISTED
Ellie Mae Inc
ELLI
| – | – |
-112,840
| Closed | -$11.1M |
|
|
ZGNX
89
DELISTED
Zogenix, Inc.
ZGNX
| – | – |
-25,815
| Closed | -$1.42M |
|
Similar funds
CI
WPP
CFM
LHC
AAM
RCI
SCM
SC
Gagnon Securities's Q2 2019 Portfolio in Review
As of Q2 2019, Gagnon Securities held 100 positions worth $464M, up 1.1% from $459M the previous quarter. Its ten largest holdings account for 43% of the portfolio.
Gagnon Securities's Q2 2019 filing shows 3 new, 45 increased, 38 reduced and 3 closed positions. Its largest new stake was Pacira BioSciences: 278,613 shares worth $12.1M. The largest sale was Amber Road Inc, an estimated $12M.
By sector, the portfolio is most concentrated in Healthcare at 25% of assets, up from 22% a quarter earlier, followed by Technology and Industrials.
- Gagnon Securities's largest Q2 2019 buy was Pacira BioSciences: 278,613 shares worth $12.1M.
- Gagnon Securities added most to Zuora, Inc. in Q2 2019, an estimated $6.35M increase.
- Gagnon Securities's biggest Q2 2019 reduction was Instructure, Inc., cutting an estimated $2.59M.
- Gagnon Securities fully exited Amber Road Inc in Q2 2019, selling an estimated $12M.
- Gagnon Securities's ten largest holdings make up 43% of its $464M portfolio in Q2 2019.
- Gagnon Securities opened 3 new positions and closed 3 in Q2 2019.
- Gagnon Securities's portfolio value rose 1.1% quarter-over-quarter to $464M.
Based on Gagnon Securities's 13F filing for Q2 2019, filed 12 Aug 2019.